Participants were randomized to receive treatment with @ - estradiol @mg/day ; @ - estradiol @mg/day and terbutaline @mg/day ( selective B@AR agonist ) ; propranolol @mg/day ( non-selective B-AR antagonist ) ; or no treatment during @weeks .